Thursday, March 10, 2011

Ghost writing - POGO gets NIH's view

The Project on Government Oversight has obtained an interesting response from the NIH about the issue of ghost writing (POGO site has links).  

In many of our off-label cases, we see pharma paying Key Opinion Leaders or the KOLs allowing their names to be used on articles (usually retrospecitve case studies) written by ghost writers (often by the pharma company).  The purpose, of course, is to make it appear that a prominent researcher (the KOL) actually did the study, giving more credibility to the "study" or off-label uses.

Question: in other disciplines (e.g., engineering, business, and so on) is there the same amount of ghost writing as in the pharma industry. 

No comments:

Post a Comment